CD4 and head and neck squamous cell carcinoma: Previously, we found that HNSCC-derived factors reduce the proliferation of immune cells, decrease the expression of pro-inflammatory cytokines (IL-12, IL-17A) and inhibit activation and polarization of CD4+ T cells to the Th17 phenotype [19].